For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Akebia Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 38

% Expired Patents = 5.3

CIPO Patents = 4

EPO Patents = 9

Trademarks = 4

Forward Citations = 431

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

James Densmore Copp (14 out of 17 patents)

Artem G Evdokimov (11 out of 58 patents)

Richard Masaru Kawamoto (11 out of 18 patents)

4. Angelique Sun Boyer (11 out of 15 patents)

5. Namal Chithranga Warshakoon (11 out of 15 patents)

6. Kenneth D Greis (10 out of 15 patents)

7. Shengde Wu (10 out of 14 patents)

8. Christopher M Lanthier (8 out of 8 patents)

9. Anne Luong (8 out of 8 patents)

10. Boris Gorin (7 out of 32 patents)

11. Ann W Newman (7 out of 8 patents)

12. John M Janusz (7 out of 37 patents)

13. Jan Oudenes (6 out of 18 patents)

14. Craig Edward Dixon (6 out of 10 patents)

15. Alan Quigbo Lu (5 out of 5 patents)

Core Competencies:

PHD Inhibitor Compounds

Vadadustat

Nitrogen-Containing Heteroarylcarboxamide

Anemia Treatment

HIF-alpha Stabilizer

Solid Forms

Prolyl Hydroxylase Inhibitors

Hypoxia Inducible Factor

38 patents: Sort by Forward Citations

1. 12753161 - PHD inhibitor compounds, compositions, and use (2026-10-06),

2. 12703691 - PHD inhibitor compounds, compositions, and their use (2026-08-11),

3. 12697330 - Therapeutic methods using vadadustat (2026-08-04),

4. 12673919 - Process for preparing [(3-hydroxypyridine-2-carbonyl)aminojalkanoic acids, esters and amides (2026-07-07),

5. 12629357 - Treatment of viral infections, of organ injury, and of related conditions using a HIF prolyl hydroxylase inhibitor or a HIF-alpha stabilizer (2026-05-19),

6. 12612367 - Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative (2026-04-28),

7. 12419877 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2025-09-23),

8. 12269802 - Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino] acetic acid (2025-04-08),

9. 11883386 - Prolyl hydroxylase inhibitors and methods of use (2024-01-30),

10. 11857543 - Compositions and methods for treating anemia (2024-01-02),

11. 11844756 - Compositions and methods for treating anemia (2023-12-19),

12. 11713298 - Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid (2023-08-01),

13. 11690836 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2023-07-04),

14. 11524939 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid (2022-12-13),

15. 11426393 - Prolyl hydroxylase inhibitors and methods of use (2022-08-30),

Company Overview

Akebia Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies for patients with kidney disease. The company specializes in advancing treatments that target the underlying mechanisms of renal disorders, particularly through the modulation of hypoxia-inducible factors. Akebia's research emphasizes the importance of improving patient outcomes and quality of life, leveraging cutting-edge science to address significant unmet medical needs in the field of nephrology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

38 Patents

#75 in Cambridge, MA

#526 in Massachusetts

#9,035 in US

#17,870 in the World

Cambridge, MA, United States of America

Akebia Therapeutics, Inc.

Forward Citations = 431

54 inventors:

James Densmore Copp (14 out of 17 patents)

Artem G Evdokimov (11 out of 58 patents)

Richard Masaru Kawamoto (11 out of 18 patents)

4. Angelique Sun Boyer (11 out of 15 patents)

5. Namal Chithranga Warshakoon (11 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akebia Therapeutics, Inc.. Retrieved from https://idiyas.com/company/akebia-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…